Renzo A. Knol

In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy

Oscar Escalona-Rayo, Ye Zeng, Renzo A. Knol et al. · Biomedicine & Pharmacotherapy · 2023 · 78 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

Lipid nanoparticle-based mRNA candidates elicit potent T cell responses

Ye Zeng, Oscar Escalona-Rayo, Renzo A. Knol et al. · Biomaterials Science · 2022 · 46 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

Lipid-Based Nanoparticle Functionalization with Coiled-Coil Peptides for <i>In Vitro</i> and <i>In Vivo</i> Drug Delivery

Dennis Aschmann, Renzo A. Knol, Alexander Kros · Accounts of Chemical Research · 2024 · 31 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

<i>In vivo</i> biodistribution of kinetically stable Pt₂L₄ nanospheres that show anti-cancer activity

Eduard O. Bobylev, Renzo A. Knol, Simon Mathew et al. · Chemical Science · 2023 · 23 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Phase‐Separated Lipid‐Based Nanoparticles: Selective Behavior at the Nano‐Bio Interface

Panagiota Papadopoulou, Rianne van der Pol, Niek van Hilten et al. · Advanced Materials · 2023 · 11 citations · Full text

Pharmacy, Biochemistry, Pharmaceutics +17